SKI Market

Indian Indices

Sensex

83,674.92 -558.72
( -0.66%)

Global Indices

Nasdaq

50,155.23 -53.92
(-0.11%)

Dow Jones

6,964.65 1.84
(0.03%)

Hang Seng

57,686.98 36.44
(0.06%)

Nikkei 225

10,491.19 137.35
(1.33%)

Forex

USD-INR

90.60 -0.06
(-0.06%)

EUR-INR

107.84 0.20
(0.18%)

GBP-INR

123.81 0.16
(0.13%)

JPY-INR

0.58 0.00
(0.79%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Sun Pharma Advanced Research Company Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

532872

INE232I01014

-10.7465221

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SPARC

4442.7

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	71.77	75.55	238.78	137.25	252.96	76.81
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	71.77	75.55	238.78	137.25	252.96	76.81
Other Income	1.79	29.47	10.88	6.84	5.41	9.76
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	73.56	105.02	249.66	144.09	258.37	86.57
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	18.27	18.18	23.93
Power & Fuel Cost	6.33	6.14	5.75	4.62	4.60	5.14
Employee Cost	108.96	118.53	107.00	98.31	91.59	93.09
Other Manufacturing Expenses	48.01	55.37	45.51	17.06	17.93	10.59
Selling & Administrative Expenses	230.99	292.27	289.71	183.33	252.17	247.28
Miscellaneous Expenses	4.75	7.03	4.87	2.41	3.48	6.81
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	399.04	479.34	452.84	324.00	387.94	386.83
Operating Profit	-325.48	-374.32	-203.18	-179.90	-129.57	-300.25
Interest	8.91	1.66	7.63	13.33	10.65	2.67
Gross Profit	-334.39	-375.98	-210.81	-193.23	-140.22	-302.92
Depreciation	10.83	12.13	11.77	10.16	10.92	9.48
Profit Before Tax	-345.22	-388.11	-222.58	-203.39	-151.14	-312.40
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	-345.22	-388.11	-222.58	-203.40	-151.14	-312.40
Extraordinary Items	0.03	0.58	-0.11	4.89	0.26	6.27
Adjusted Net Profit	-345.25	-388.69	-222.47	-208.29	-151.40	-318.67
Adjustment below Net Profit	-0.26	0.19	1.35	1.70	1.53	-2.47
P & L Balance brought forward	-1979.73	-1591.81	-1370.58	-1168.88	-1019.27	-704.40
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-2325.21	-1979.73	-1591.81	-1370.58	-1168.88	-1019.27
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-10.64	-11.96	-6.86	-7.48	-5.77	-11.92
Earnings Per Share(Adj)-Unit Curr	-10.64	-11.96	-6.86	-7.48	-5.77	-11.92
Book Value-Unit Curr	-6.80	3.85	15.80	-7.47	-6.42	-0.71
Book Value(Adj)-Unit Curr	-6.80	3.85	15.80	-7.47	-6.42	-0.71

83,674.92 -558.72 ( -0.66%)

50,155.23 -53.92 (-0.11%)

6,964.65 1.84 (0.03%)

57,686.98 36.44 (0.06%)

10,491.19 137.35 (1.33%)

90.60 -0.06 (-0.06%)

107.84 0.20 (0.18%)

123.81 0.16 (0.13%)

0.58 0.00 (0.79%)